title: Prognostic factors in patients with primary invasive vaginal carcinoma.
abstract: OBJECTIVE
  Aim of the study was the assessment of prognostic factors in the group of primary invasive vaginal carcinoma (PIVC) patients subjected to radical radiation therapy
  
  
  METHODS
  The analysis was performed for the group of 152 PIVC patients treated with intracavitary brachytherapy alone (16.5%), the combination of brachytherapy and external radiotherapy (78.9%), or external radiotherapy alone (4.6%). The relationship was investigated between treatment outcome and the following demographic, clinical and histopathological features: age, duration of pathological symptoms, number of births given, prior hysterectomy haemoglobin level, Karnofsky performance status score, primary tumour location in vagina, length of vagina involved, FIGO stage, gross appearance, histological type, and tumour grade.
  
  
  RESULTS
  Five-year disease-free survival was observed in 46.1% of the patients (70/152). Patients below 60 years of age, with Karnofsky score of 80-90, diagnosed with PIVC in stage 10 or 110, and with tumour of grade G1 or G2 had significantly higher 5-year disease-free survival. Multifactoral analysis showed that age below 60 and FIGO stage 10 and 110 are independent favourable prognostic factors.
  
  
  CONCLUSIONS
  The independent prognostic factors in PIVC patients treated with radical radiotherapy are patient age and FIGO stage.
authors.affiliation: Gynaecology Department, Centre of Oncology, Maria Sklodowska-Curie Memorial Institute, Krakow Branch, Poland. pawel.blecharz@interia.pl
authors.forename: Paweł
authors.initials: P
authors.lastname: Blecharz
authors.forename: Marian
authors.initials: M
authors.lastname: Reinfuss
authors.forename: Jerzy
authors.initials: J
authors.lastname: Jakubowicz
authors.forename: Skotnicki
authors.initials: S
authors.lastname: Piotr
authors.forename: Wojciech
authors.initials: W
authors.lastname: Wysocki
authors.forename: Kazimierz
authors.initials: K
authors.lastname: Karolewski
authors.forename: Krzysztof
authors.initials: K
authors.lastname: Urbański
mesh_terms: D000328:Adult; D000368:Aged; D001918:Brachytherapy / Q000379:methods*; D002277:Carcinoma / Q000473:pathology / Q000532:radiotherapy*; D003131:Combined Modality Therapy; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D008875:Middle Aged; D009367:Neoplasm Staging; D011044:Poland; D011379:Prognosis; D011879:Radiotherapy Dosage; D011881:Radiotherapy, Computer-Assisted / Q000379:methods*; D016019:Survival Analysis; D016896:Treatment Outcome; D014625:Vaginal Neoplasms / Q000473:pathology / Q000532:radiotherapy*; D016387:Women's Health